Matches in Wikidata for { <http://www.wikidata.org/entity/Q66076727> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q66076727 description "clinical trial" @default.
- Q66076727 description "ensayu clínicu" @default.
- Q66076727 description "klinisch onderzoek" @default.
- Q66076727 description "клінічне випробування" @default.
- Q66076727 name "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 name "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 type Item @default.
- Q66076727 label "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 label "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 prefLabel "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 prefLabel "A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 P1132 Q66076727-3143BE73-CA52-4121-8841-6625BF450AEA @default.
- Q66076727 P1476 Q66076727-3C590B95-9703-42A0-88F0-A50BE8DEEE34 @default.
- Q66076727 P17 Q66076727-210CCB82-1D64-460D-B37C-7E59F0F2D508 @default.
- Q66076727 P17 Q66076727-2F3E5FCE-84AB-4A4F-92ED-B3F7E244EF1F @default.
- Q66076727 P17 Q66076727-3AACE204-50F5-4897-A3B0-70773FC0BB02 @default.
- Q66076727 P17 Q66076727-429C975C-F3DC-47DF-87DE-FE162418A5FF @default.
- Q66076727 P17 Q66076727-9AFEEB90-C853-4388-A9D9-F73E339EF827 @default.
- Q66076727 P17 Q66076727-A64FF8D3-00E5-4E5A-AEDD-48720A7C223D @default.
- Q66076727 P17 Q66076727-AAF7E771-E9E4-4718-A7ED-8E8D52B59EED @default.
- Q66076727 P17 Q66076727-AE9A0621-FB40-4052-8CF9-D3127FC870D2 @default.
- Q66076727 P1813 Q66076727-0D1FEBC5-71E1-4370-BC39-39759FD779B3 @default.
- Q66076727 P2899 Q66076727-400E50F0-D0B9-4712-854E-C1D8C71145D1 @default.
- Q66076727 P3098 Q66076727-84AB3087-A198-44D1-8D5F-361E0CC9CCD6 @default.
- Q66076727 P31 Q66076727-CD753F43-ACE8-4BBB-8AA6-72F920C833B5 @default.
- Q66076727 P580 Q66076727-A5F39A9E-DBAB-418B-91D4-776407A03F4F @default.
- Q66076727 P582 Q66076727-5072BC5C-FD29-4AFE-9DB0-A40864D1363A @default.
- Q66076727 P6099 Q66076727-598969FB-94A4-4AEE-8143-8A1F52224B98 @default.
- Q66076727 P6153 Q66076727-26F77B68-6140-46E9-9774-A422F209C23C @default.
- Q66076727 P6153 Q66076727-349A8669-55F3-494A-B352-6D86CED5838F @default.
- Q66076727 P6153 Q66076727-4A2562A7-5A5F-4A5B-9F1E-9850C6DF8B17 @default.
- Q66076727 P6153 Q66076727-8220ED68-BFC9-40F8-9708-24373D4FCE0A @default.
- Q66076727 P6153 Q66076727-9BC1EA23-22F5-4754-BCED-16FC74E2A8F0 @default.
- Q66076727 P6153 Q66076727-9F004864-482F-4FBB-8F7D-0CA070DA6959 @default.
- Q66076727 P8363 Q66076727-54E19AEA-6869-4618-BAA8-81D0E5615C71 @default.
- Q66076727 P859 Q66076727-FC4F4491-A86D-4A15-A0CA-E420FD8575E2 @default.
- Q66076727 P1132 "+92" @default.
- Q66076727 P1476 "A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q66076727 P17 Q142 @default.
- Q66076727 P17 Q16 @default.
- Q66076727 P17 Q183 @default.
- Q66076727 P17 Q29 @default.
- Q66076727 P17 Q30 @default.
- Q66076727 P17 Q35 @default.
- Q66076727 P17 Q36 @default.
- Q66076727 P17 Q408 @default.
- Q66076727 P1813 "CheckMate 650" @default.
- Q66076727 P2899 "+18" @default.
- Q66076727 P3098 "NCT02985957" @default.
- Q66076727 P31 Q30612 @default.
- Q66076727 P580 "2017-03-17T00:00:00Z" @default.
- Q66076727 P582 "2021-06-30T00:00:00Z" @default.
- Q66076727 P6099 Q42824440 @default.
- Q66076727 P6153 Q131252 @default.
- Q66076727 P6153 Q1950740 @default.
- Q66076727 P6153 Q2944832 @default.
- Q66076727 P6153 Q49117 @default.
- Q66076727 P6153 Q6518847 @default.
- Q66076727 P6153 Q7972509 @default.
- Q66076727 P8363 Q78089383 @default.
- Q66076727 P859 Q266423 @default.